[A clinical study of auditory hallucination by single photon emission computed tomography (SPECT) using N-isopropyl-p-[123I] iodoamphetamine (IMP)]. 1988

T Gyobu, and H Matsuda, and K Hisada, and G Inao, and M Ii

UI MeSH Term Description Entries
D007457 Iodine Radioisotopes Unstable isotopes of iodine that decay or disintegrate emitting radiation. I atoms with atomic weights 117-139, except I 127, are radioactive iodine isotopes. Radioisotopes, Iodine
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D010468 Perceptual Disorders Cognitive disorders characterized by an impaired ability to perceive the nature of objects or concepts through use of the sense organs. These include spatial neglect syndromes, where an individual does not attend to visual, auditory, or sensory stimuli presented from one side of the body. Hemispatial Neglect,Hemisensory Neglect,Sensory Neglect,Somatosensory Discrimination Disorder,Discrimination Disorder, Somatosensory,Discrimination Disorders, Somatosensory,Hemisensory Neglects,Hemispatial Neglects,Neglect, Hemisensory,Neglect, Hemispatial,Neglect, Sensory,Neglects, Hemisensory,Perceptual Disorder,Sensory Neglects,Somatosensory Discrimination Disorders
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D000662 Amphetamines Analogs or derivatives of AMPHETAMINE. Many are sympathomimetics and central nervous system stimulators causing excitation, vasopressin, bronchodilation, and to varying degrees, anorexia, analepsis, nasal decongestion, and some smooth muscle relaxation.

Related Publications

T Gyobu, and H Matsuda, and K Hisada, and G Inao, and M Ii
November 1987, Kaku igaku. The Japanese journal of nuclear medicine,
T Gyobu, and H Matsuda, and K Hisada, and G Inao, and M Ii
April 1985, Kaku igaku. The Japanese journal of nuclear medicine,
T Gyobu, and H Matsuda, and K Hisada, and G Inao, and M Ii
April 1988, Nihon Igaku Hoshasen Gakkai zasshi. Nippon acta radiologica,
T Gyobu, and H Matsuda, and K Hisada, and G Inao, and M Ii
January 1990, European journal of nuclear medicine,
T Gyobu, and H Matsuda, and K Hisada, and G Inao, and M Ii
September 1992, No to hattatsu = Brain and development,
T Gyobu, and H Matsuda, and K Hisada, and G Inao, and M Ii
May 1988, Kaku igaku. The Japanese journal of nuclear medicine,
T Gyobu, and H Matsuda, and K Hisada, and G Inao, and M Ii
January 1995, European neurology,
T Gyobu, and H Matsuda, and K Hisada, and G Inao, and M Ii
March 1988, Neurologia medico-chirurgica,
T Gyobu, and H Matsuda, and K Hisada, and G Inao, and M Ii
October 2005, Internal medicine (Tokyo, Japan),
T Gyobu, and H Matsuda, and K Hisada, and G Inao, and M Ii
January 2006, Japanese journal of ophthalmology,
Copied contents to your clipboard!